Prostate Cancer Coverage from Every Angle

Daniel E. Spratt, MD, on Pros and Cons of Antiandrogen Treatment in Prostate Cancer

Posted: Monday, September 23, 2019

Daniel E. Spratt, MD, of the University of Michigan, talks about how to explain the pros and cons of antiandrogen treatment to men with different stages of prostate cancer, including the difficult discussion about the fact that aggressive therapy is likely to lead to side effects and reduced quality of life.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.